◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

SUPERNUS PHARMACEUTICALS, INC.

CIK: 1356576 SIC: 2834
$718.95M
Revenue
$-38.55M
Net Income
89.63%
Gross Margin
-8.66%
Op. Margin
$164.62M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 10 of 13 annual reports available (2012 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
+ Total Revenue $718.95M $718.95M $661.82M $607.52M $667.24M $579.77M $520.40M $392.75M $408.90M $302.24M $215.00M
Revenue Growth % 0.0% 8.6% 8.9% -8.9% 15.1% 11.4% 32.5% -3.9% 35.3% 40.6% nan%
Cost of Revenue $74.56M $74.56M $77.91M $83.78M $87.22M $75.06M $52.46M $16.66M $15.36M $15.21M $11.99M
+ Gross Profit $644.39M $644.39M $583.91M $523.74M $580.02M $504.71M $467.94M $376.10M $393.54M $287.02M $203.02M
Gross Margin % 89.6% 89.6% 88.2% 86.2% 86.9% 87.1% 89.9% 95.8% 96.2% 95.0% 94.4%
Operating Expenses $781.24M $781.24M $580.15M $612.79M $621.11M $493.75M $346.70M $244.18M $264.45M $202.70M $160.79M
Research & Development $106.23M $106.23M $108.80M $91.59M $74.55M $90.47M $75.96M $69.10M $89.21M $49.58M $42.79M
Selling General & Admin $485.56M $485.56M $321.58M $336.36M $377.22M $304.76M $200.68M $158.43M $159.89M $137.91M $106.01M
+ Operating Income $-62.28M $-62.28M $81.67M $-5.27M $46.12M $86.03M $173.70M $148.57M $144.44M $99.54M $54.22M
Operating Margin % -8.7% -8.7% 12.3% -0.9% 6.9% 14.8% 33.4% 37.8% 35.3% 32.9% 25.2%
Interest Expense - - - $1.32M $2.52M $2.52M $2.52M $2.52M $13.84M $134.00K $543.00K
Interest Income - - - - - - - - $13.84M $2.86M $1.48M
Other Income/Expense $13.25M $13.25M $16.20M $8.04M $14.62M $-12.85M $-5.05M $-1.08M $-4.27M $1.08M $-15.00K
Income Before Tax $-49.03M $-49.03M $97.87M $2.77M $60.74M $73.17M $168.65M $147.49M $140.18M $100.62M $50.37M
Income Tax Expense $-10.48M $-10.48M $24.00M $1.45M $32.00K $19.75M $41.70M $34.43M $29.18M $43.33M $-40.85M
+ Net Income $-38.55M $-38.55M $73.86M $1.32M $60.71M $53.42M $126.95M $113.06M $110.99M $57.28M $91.22M
Net Margin % -5.4% -5.4% 11.2% 0.2% 9.1% 9.2% 24.4% 28.8% 27.1% 19.0% 42.4%
Basic EPS -0.68 -0.68 1.34 0.02 1.13 1.01 2.41 2.16 2.13 1.13 1.84
Diluted EPS -0.68 -0.68 1.32 0.02 1.04 0.98 2.36 2.10 2.05 1.08 1.76
Basic Shares Outstanding - 56.5M 55.1M 54.5M 53.7M 53.1M 52.6M 52.4M 52.0M 50.8M 49.5M
Diluted Shares Outstanding - 56.5M 56.0M 55.5M 61.7M 54.4M 53.7M 53.8M 54.1M 53.3M 51.7M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Cash & Cash Equivalents $128.45M $69.33M $75.05M $93.12M $203.43M $288.64M $181.38M $192.25M $100.30M $66.40M
Short-term Investments - - $179.82M $368.21M $136.25M $133.89M $165.69M $163.77M $39.74M $23.72M
Accounts Receivable $187.80M $142.08M $144.16M $165.50M $148.93M $140.88M $87.33M $102.92M $65.59M $41.53M
Inventory $112.48M $54.29M $77.41M $91.54M $85.96M $48.33M $26.63M $25.66M $16.30M $16.80M
Other Current Assets $65.33M $36.09M $16.68M $15.78M $27.02M $18.68M $11.61M $8.89M $6.52M $2.96M
Total Current Assets $644.18M $686.07M $493.11M $734.15M $601.59M $630.42M $472.64M $493.49M $228.45M $151.40M
Property Plant & Equipment $10.53M $11.54M $13.53M - - $37.82M $17.07M $4.09M $5.12M $4.34M
Goodwill $124.88M $117.02M $117.02M $117.02M $117.52M $77.91M - - - -
Intangible Assets $569.46M $521.91M $599.89M $702.46M $784.69M $364.34M $24.84M $31.37M $36.02M $16.49M
Long-term Investments - - $16.62M $93.90M $119.17M $350.36M $591.77M $418.80M $133.64M $75.41M
Other Non-current Assets $63.80M $31.53M $37.51M $39.81M $49.23M $43.25M $615.00K $380.00K $389.00K $331.00K
Total Assets $1.45B $1.37B $1.28B $1.70B $1.69B $1.50B $1.16B $977.81M $424.46M $309.57M
Accounts Payable $2.68M $4.59M - - - - $10.14M $3.19M $6.84M $8.05M
Accrued Liabilities $107.80M $76.35M - - - - - $36.53M $27.30M $27.43M
Deferred Revenue - - - - - - - - $287.00K -
Other Current Liabilities $38.22M - $4.28M $16.86M $20.13M $9.08M $3.24M - - -
Total Current Liabilities $338.17M $292.40M $290.20M $687.96M $315.38M $245.11M $160.59M $161.35M $123.00M $80.74M
Deferred Tax Liabilities - $4.96M $24.96M $49.81M $85.36M $35.22M - - - -
Other Non-current Liabilities $22.19M $7.60M $6.42M $8.69M $16.38M $42.79M $9.41M $11.40M $10.58M $4.00M
Total Liabilities $390.93M $332.34M $356.16M $816.30M $873.30M $759.24M $564.85M $524.79M $156.98M $117.81M
Common Stock $57.00K $56.00K $55.00K $54.00K $53.00K $53.00K $53.00K $52.00K $51.00K $50.00K
Retained Earnings $517.88M $556.43M $482.56M $481.25M $379.92M $326.50M $199.55M $86.49M $-26.82M $-84.29M
Total Stockholders Equity $1.06B $1.04B $921.52M $886.20M $815.85M $744.86M $595.43M $453.02M $267.48M $191.75M
Total Liabilities & Equity $1.45B $1.37B $1.28B $1.70B $1.69B $1.50B $1.16B $977.81M $424.46M $309.57M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Net Income $-38.55M $-38.55M $73.86M $1.32M $60.71M $53.42M $126.95M $113.06M $110.99M $57.28M $91.22M
Depreciation & Amortization $153.69M $91.56M $80.41M $84.86M $85.54M $32.59M $18.14M $6.66M $7.06M $8.13M $2.40M
Stock-based Compensation $56.69M $33.05M $27.75M $26.76M $17.57M $17.91M $16.56M $14.85M $11.29M $8.43M $5.93M
Deferred Income Tax $-9.94M $5.21M $-20.14M $-25.71M $-26.32M $-4.99M $568.00K $-5.83M $-4.17M $21.22M $-41.79M
Change in Receivables $24.62M $22.30M $-2.08M $-18.77M $16.37M $-3.87M $34.61M $-15.75M $35.86M $24.06M $15.62M
Change in Inventory $-6.85M $7.50M $-15.81M $-6.11M $17.86M $14.58M $10.12M $969.00K $9.36M $-497.00K $4.21M
Change in Payables - - - - - - - $6.96M $-3.58M $-620.00K $3.47M
Operating Cash Flow $167.06M $47.33M $171.95M $111.08M $116.83M $127.13M $138.40M $143.13M $128.99M $114.64M $66.81M
Capital Expenditure $2.45M $1.34M $725.00K $551.00K $412.00K - $3.45M $2.74M $844.00K $2.03M $1.60M
Acquisitions - $293.09M - - - $950.00K $298.54M - - - -
Purchases of Investments - - - - - - $95.89M $409.71M $491.65M $101.89M $47.36M
Sales of Investments $1.20B $774.48M $498.87M $370.90M $190.74M - - - - - -
Investing Cash Flow $48.13M $4.11M $-189.87M $268.73M $-216.66M $-81.91M $-34.70M $-157.92M $-413.48M $-86.42M $-35.96M
Stock Issued $44.98M $37.62M $14.91M $6.61M $12.42M $7.09M $4.36M $3.93M $11.58M $5.68M $2.05M
Financing Cash Flow $-32.73M $9.13M $12.19M $-397.88M $-10.48M $-130.42M $3.56M $3.93M $376.44M $5.68M $2.05M
Net Change in Cash $182.46M $60.57M $-5.72M $-18.07M $-110.31M $-85.21M $107.26M $-10.87M $91.94M $33.91M $32.90M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $192.10M - $507.38M -
Cost of Revenue $18.96M - $51.55M -
Operating Expenses $252.33M - $565.73M -
Research & Development $29.37M - $78.41M -
Selling General & Admin $179.68M - $363.17M -
Operating Income $-60.23M - $-58.35M -
Other Income/Expense $2.28M - $11.23M -
Income Before Tax $-57.95M - $-47.12M -
Income Tax Expense $-12.84M - $-12.67M -
Net Income $-45.12M $19.92M $-34.45M -
Basic EPS -0.80 - -0.61 -
Diluted EPS -0.80 - -0.61 -
Basic Shares Outstanding $56.55M - $56.13M -
Diluted Shares Outstanding $56.55M - $56.13M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $151.37M $69.33M
Accounts Receivable $171.25M $142.08M
Other Current Assets $62.08M $36.09M
Total Current Assets $593.89M $686.07M
Property Plant & Equipment $10.63M $11.54M
Goodwill $119.08M $117.02M
Intangible Assets $623.48M $521.91M
Other Non-current Assets $62.43M $31.53M
Total Assets $1.42B $1.37B
Other Current Liabilities $26.32M -
Total Current Liabilities $330.63M $292.40M
Deferred Tax Liabilities - $4.96M
Other Non-current Liabilities $7.82M $7.60M
Total Liabilities $370.09M $332.34M
Common Stock $57.00K $56.00K
Retained Earnings $521.98M $556.43M
Total Stockholders Equity $1.05B $1.04B
Total Liabilities & Equity $1.42B $1.37B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-45.12M $19.92M $-34.45M -
Depreciation & Amortization - - $66.55M -
Stock-based Compensation - - $23.40M -
Deferred Income Tax - - $-13.80M -
Change in Receivables - - $5.88M -
Change in Inventory - - $3.32M -
Operating Cash Flow - - $27.47M -
Capital Expenditure - - $911.00K -
Acquisitions - - $293.09M -
Sales of Investments - - $735.16M -
Investing Cash Flow - - $55.42M -
Stock Issued - - $29.06M -
Financing Cash Flow - - $604.00K -
Net Change in Cash - - $83.49M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...